Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 9, 2015
Nivolumab in Resected and Unresectable Metastatic Melanoma: Characteristics of Immune-Related Adverse Events and Association with Outcomes
Morganna Freeman-Keller, Youngchul Kim, Heather Cronin, et al.
Glia
|
March 19, 2019
Knockdown of circulating C1 inhibitor induces neurovascular impairment, glial cell activation, neuroinflammation, and behavioral deficits
Dorit Farfara, Emily Feierman, Allison Richards, et al.
Journal of Comparative Effectiveness Research
|
August 15, 2017
Stakeholders' views on data sharing in multicenter studies
Kathleen M Mazor, Allison Richards, Mia Gallagher, et al.
Cancer Immunology Research
|
February 14, 2016
Phase I/II Study of Metastatic Melanoma Patients Treated with Nivolumab Who Had Progressed after Ipilimumab
Jeffrey Weber, Geoffrey Gibney, Ragini Kudchadkar, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
January 14, 2021
Expanded Tumor-infiltrating Lymphocytes From Soft Tissue Sarcoma Have Tumor-specific Function
John E Mullinax, MacLean Hall, Matthew Beatty, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 16, 2019
BRAF Targeting Sensitizes Resistant Melanoma to Cytotoxic T Cells
Cigdem Atay, Taekyoung Kwak, Sergio Lavilla-Alonso, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 20, 2014
Safety, correlative markers, and clinical results of adjuvant nivolumab in combination with vaccine in resected high-risk metastatic melanoma
Geoffrey T Gibney, Ragini R Kudchadkar, Ronald C DeConti, et al.
Frontiers in Oncology
|
March 20, 2018
Combination of Ipilimumab and Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes for Patients with Metastatic Melanoma
John E Mullinax, MacLean Hall, Sangeetha Prabhakaran, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 17, 2024
Neoadjuvant Intratumoral Plasmid IL-12 Electro-Gene-Transfer and Nivolumab in Patients with Operable, Locoregionally Advanced Melanoma
Ahmad A Tarhini, Zeynep Eroglu, Islam Eljilany, et al.
Research Square
|
September 15, 2025
Pembrolizumab and Olaparib (POLAR) Maintenance Therapy in Metastatic Pancreatic Cancer With or Without Homologous Repair Deficiency: A Biomarker Selected Phase II Trial
Wungki Park, Catherine O'Connor, Joanne Chou, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 9, 2015
Nivolumab in Resected and Unresectable Metastatic Melanoma: Characteristics of Immune-Related Adverse Events and Association with Outcomes
Morganna Freeman-Keller, Youngchul Kim, Heather Cronin, et al.
Glia
|
March 19, 2019
Knockdown of circulating C1 inhibitor induces neurovascular impairment, glial cell activation, neuroinflammation, and behavioral deficits
Dorit Farfara, Emily Feierman, Allison Richards, et al.
Journal of Comparative Effectiveness Research
|
August 15, 2017
Stakeholders' views on data sharing in multicenter studies
Kathleen M Mazor, Allison Richards, Mia Gallagher, et al.
Cancer Immunology Research
|
February 14, 2016
Phase I/II Study of Metastatic Melanoma Patients Treated with Nivolumab Who Had Progressed after Ipilimumab
Jeffrey Weber, Geoffrey Gibney, Ragini Kudchadkar, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
January 14, 2021
Expanded Tumor-infiltrating Lymphocytes From Soft Tissue Sarcoma Have Tumor-specific Function
John E Mullinax, MacLean Hall, Matthew Beatty, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 16, 2019
BRAF Targeting Sensitizes Resistant Melanoma to Cytotoxic T Cells
Cigdem Atay, Taekyoung Kwak, Sergio Lavilla-Alonso, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 20, 2014
Safety, correlative markers, and clinical results of adjuvant nivolumab in combination with vaccine in resected high-risk metastatic melanoma
Geoffrey T Gibney, Ragini R Kudchadkar, Ronald C DeConti, et al.
Frontiers in Oncology
|
March 20, 2018
Combination of Ipilimumab and Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes for Patients with Metastatic Melanoma
John E Mullinax, MacLean Hall, Sangeetha Prabhakaran, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 17, 2024
Neoadjuvant Intratumoral Plasmid IL-12 Electro-Gene-Transfer and Nivolumab in Patients with Operable, Locoregionally Advanced Melanoma
Ahmad A Tarhini, Zeynep Eroglu, Islam Eljilany, et al.
Research Square
|
September 15, 2025
Pembrolizumab and Olaparib (POLAR) Maintenance Therapy in Metastatic Pancreatic Cancer With or Without Homologous Repair Deficiency: A Biomarker Selected Phase II Trial
Wungki Park, Catherine O'Connor, Joanne Chou, et al.
Page
of 1